NEOGENOMICS INC — Director's Dealing 2024

Mar 6, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2024-03-04

Reporting Person: TETRAULT LYNN A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-04	Common Stock	S	6112	$15.9651	Disposed	50062	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$22.52	2026-06-06	Common Stock (2136)	2136	Direct
Stock Option (Right to Buy)	$28.54	2027-05-28	Common Stock (3448)	3448	Direct
Stock Option (Right to Buy)	$40.90	2028-06-02	Common Stock (3714)	3714	Direct
Stock Option (Right to Buy)	$41.76	2028-10-11	Common Stock (972)	972	Direct
Stock Option (Right to Buy)	$8.10	2029-06-10	Common Stock (13882)	13882	Direct
Stock Option (Right to Buy)	$14.82	2033-08-10	Common Stock (8353)	8353	Direct
Restricted Stock Unit	$0		Common Stock (11336)	11336	Direct

Footnotes

F1: Once vested, the shares of common stock are not subject to expiration.